OPCH FY2025 EPS Estimate Reduced by Barrington Research

Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Analysts at Barrington Research decreased their FY2025 earnings per share (EPS) estimates for Option Care Health in a report issued on Thursday, October 31st. Barrington Research analyst M. Petusky now expects that the company will post earnings of $1.12 per share for the year, down from their previous estimate of $1.40. Barrington Research has a "Outperform" rating and a $32.00 price target on the stock. The consensus estimate for Option Care Health's current full-year earnings is $1.23 per share. Barrington Research also issued estimates for Option Care Health's FY2026 earnings at $1.32 EPS.

Other research analysts also recently issued reports about the stock. Truist Financial lowered their price objective on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and set a $27.00 price target for the company. in a research note on Monday. Bank of America downgraded shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group lowered Option Care Health from a "buy" rating to a "hold" rating and cut their target price for the company from $38.00 to $26.00 in a report on Thursday. Finally, JMP Securities upped their price target on Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research note on Monday, September 30th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Option Care Health has an average rating of "Moderate Buy" and an average price target of $30.83.

Option Care Health Stock Down 6.7 %

NASDAQ:OPCH traded down $1.62 on Monday, hitting $22.49. 3,605,767 shares of the company's stock traded hands, compared to its average volume of 1,483,424. The company has a market cap of $3.83 billion, a PE ratio of 19.16, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32. Option Care Health has a 1 year low of $22.46 and a 1 year high of $34.63. The company has a current ratio of 1.73, a quick ratio of 1.36 and a debt-to-equity ratio of 0.77. The firm has a 50-day moving average price of $30.49 and a 200-day moving average price of $29.91.

Insider Activity at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company's stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares of the company's stock, valued at $663,429.51. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the company's stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

A number of hedge funds have recently made changes to their positions in the business. UMB Bank n.a. raised its position in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after buying an additional 1,446 shares during the period. Blue Trust Inc. boosted its stake in Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after buying an additional 377 shares in the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in Option Care Health in the 1st quarter valued at $85,000. Institutional investors and hedge funds own 98.05% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.